Which has the lower trailing P/E, PEN or ZBH?

ZBH has the lower trailing P/E: PEN trades at 78.02 and ZBH at 21.48. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, PEN or ZBH?

Over the past five years, PEN grew revenue faster — PEN at a 17.52% CAGR versus ZBH at 2.89%.

Does PEN or ZBH pay a bigger dividend?

ZBH pays a dividend (1.09% yield), while PEN has no payments in the available dividend history.

Is PEN or ZBH more profitable?

PEN runs the higher net margin — PEN at 10.67% versus ZBH at 9.48%.

How have PEN and ZBH total returns compared?

Over the past 10 years, PEN delivered 15.37% and ZBH delivered -2.70% annualized total return. Past performance doesn't predict future results.

Penumbra, Inc. (PEN) vs Zimmer Biomet Holdings, Inc. (ZBH)

A side-by-side comparison of Penumbra, Inc. and Zimmer Biomet Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 4, 2026. Differences are shown without an overall score or investment verdict.

PEN

Penumbra, Inc.

$12.51B

$317.55HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

ZBH

Zimmer Biomet Holdings, Inc.

$17.08B

$88.29HealthcareDelayed quote: Oct 2, 2026, 4:02 PM EDT

Total return — PEN vs ZBH

growth of $100 · dividends reinvested · last 10y

PEN +317.9% (+15.4%/yr)ZBH -23.5% (-2.6%/yr)PEN compounded faster over this window

Log scale — wide-divergence pair

PEN ZBH

PEN vs ZBH: by the numbers

•ZBH is the larger company ($17.08B vs $12.51B market cap).
•ZBH trades at the lower trailing earnings multiple (21.48 vs 78.02 P/E), one valuation lens rather than an overall verdict.
•PEN converts more revenue to profit (10.67% vs 9.48% net margin).
•PEN grew revenue faster over the past five years (17.52% vs 2.89% CAGR).
•ZBH pays a dividend (1.09% yield), while PEN has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	PEN	ZBH
P/E ratio	78.02	21.48
Forward P/E	67.45	10.35
P/S ratio	8.31	2.01
P/B ratio	8.17	1.35
EV / EBITDA	61.21	10.33
FCF yield	1.73%	N/A

Profitability

Metric	PEN	ZBH
Gross margin	67.84%	61.62%
Operating margin	12.45%	15.73%
Net margin	10.67%	9.48%
ROE	10.49%	6.39%
ROIC	8.48%	5.51%

Dividends

Metric	PEN	ZBH
Dividend yield	N/A	1.09%
Payout ratio	N/A	23.36%

Growth (annualized)

Metric	PEN	ZBH
Revenue CAGR (5Y)	17.52%	2.89%
Total return CAGR (5Y)	3.83%	-8.64%

Frequently asked

Which has the lower trailing P/E, PEN or ZBH?: ZBH has the lower trailing P/E: PEN trades at 78.02 and ZBH at 21.48. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, PEN or ZBH?: Over the past five years, PEN grew revenue faster — PEN at a 17.52% CAGR versus ZBH at 2.89%.
Does PEN or ZBH pay a bigger dividend?: ZBH pays a dividend (1.09% yield), while PEN has no payments in the available dividend history.
Is PEN or ZBH more profitable?: PEN runs the higher net margin — PEN at 10.67% versus ZBH at 9.48%.
How have PEN and ZBH total returns compared?: Over the past 10 years, PEN delivered 15.37% and ZBH delivered -2.70% annualized total return. Past performance doesn't predict future results.

Go deeper

Full PEN analysis Full ZBH analysis Interactive comparison tool

Dig into the metrics

Penumbra P/E ratio Zimmer Biomet P/E ratio Zimmer Biomet dividend yield Penumbra ROE Zimmer Biomet ROE Penumbra operating margin Zimmer Biomet operating margin Penumbra revenue growth Zimmer Biomet revenue growth Penumbra free cash flow Zimmer Biomet free cash flow

Penumbra & Zimmer Biomet appear in these rankings

Fastest Revenue Growth Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 4, 2026.